BIOVAXYS ANNOUNCES COMPLETED DEBT SETTLEMENT

VANCOUVER, British Columbia, Oct. 14, 2022 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC-QB: BVAXF) (“BioVaxys” or the “Company”) announces that, further to its news release dated October 6, 2022, it has settled an aggregate of $300,000 in debt through the issuance…

About the Author

has written 41314 stories on this site.

Copyright © 2010 Business and Corporate News.